Unfractionated Heparin Infusion: Evidence‑Based Dosing and Monitoring

Therapeutic aPTT Range and Reagent Variability

The commonly quoted “1.5‑2.5 × control” aPTT ratio is unreliable because different aPTT reagents and coagulometers yield widely divergent results for the same heparin concentration, making the rule unsafe to apply universally. 1
Modern aPTT reagents can produce ratios ranging from 1.6‑2.7 × control up to 3.7‑6.2 × control when measuring therapeutic heparin levels of 0.3‑0.7 anti‑Xa U/mL. 1
Institutions must establish their own therapeutic aPTT range calibrated to the specific reagent and analyzer they use; the same heparin concentration may generate aPTT values from 48 s to 108 s depending on the testing system. 1

A lower initial regimen is recommended: 60‑70 units/kg IV bolus (maximum 4,000‑5,000 units) followed by 12‑15 units/kg/h infusion (maximum 1,000 units/h). 2
This reduced dosing is essential because higher doses in ACS patients receiving antiplatelet agents markedly increase bleeding risk. 2

The first aPTT should be drawn 6 hours after the initial bolus to allow steady‑state distribution of heparin. 3
After any dose adjustment, re‑measure aPTT in 6 hours and continue until two consecutive therapeutic values are obtained. 2
Once the therapeutic range is achieved, check aPTT every 24 hours and whenever there is a significant clinical change (e.g., recurrent ischemia, bleeding, hypotension). 2

an aPTT < 50 s is associated with a 15‑fold increase in recurrent venous thromboembolism. 4
an aPTT of 50‑59 s still carries a 10.7‑fold increase in recurrent events. 4
Failure to reach therapeutic aPTT within the first 24 hours dramatically raises the risk of treatment failure. 4

an aPTT > 90 s raises bleeding risk without providing additional antithrombotic benefit; clinically significant bleeding remains uncommon unless invasive procedures are performed or the patient has underlying hemostatic abnormalities. 3

When a patient requires ≥ 35,000 units/24 h to achieve therapeutic aPTT, switch to anti‑factor Xa monitoring with a target range of 0.35‑0.7 U/mL. 1
Heparin resistance is often due to antithrombin deficiency, increased heparin clearance, elevated factor VIII or fibrinogen, or high levels of heparin‑binding proteins. 1
In resistant patients, dosing based on anti‑Xa levels yields similar clinical outcomes while using lower total heparin doses compared with aPTT‑guided dosing. 1

When heparin is combined with thrombolytic agents or GP IIb/IIIa antagonists, standard weight‑based dosing leads to excessive anticoagulation and increased bleeding; dosing regimens must be modified accordingly. [2][4]

Platelet counts should be checked every 2 days; a sudden unexplained drop below 100 × 10⁹/L or a > 30 % decline from baseline mandates immediate discontinuation of all heparin (including line flushes). 2
Hemoglobin/hematocrit should be monitored at least daily and whenever clinical bleeding is suspected. 2

The American College of Cardiology recommends that the therapeutic APTT range for unfractionated heparin should be 60-85 seconds, corresponding to a plasma heparin level of 0.2-0.4 U/mL by protamine titration or 0.35-0.7 U/mL by anti-factor Xa assay, for patients receiving heparin therapy 5
For pediatric patients, the target aPTT should be 60-85 seconds, reflecting an anti-factor Xa level of 0.35-0.70 U/mL, according to the American Heart Association 6

The American College of Chest Physicians recommends an initial dose of 80 units/kg bolus, then 18 units/kg/h continuous infusion, with adjustments based on aPTT results, for patients receiving heparin therapy 7, 8
For aPTT <35 seconds, give 80 units/kg bolus, then increase infusion by 4 units/kg/h, as recommended by the American College of Chest Physicians 7, 8
For aPTT 35-45 seconds, give 40 units/kg bolus, then increase infusion by 2 units/kg/h, according to the American College of Chest Physicians 7, 8
For aPTT 46-70 seconds, no change is needed, as recommended by the American College of Chest Physicians 7, 8
For aPTT 71-90 seconds, decrease infusion rate by 2 units/kg/h, according to the American College of Chest Physicians 7, 8
For aPTT >90 seconds, hold infusion for 1 hour, then decrease infusion rate by 3 units/kg/h, as recommended by the American College of Chest Physicians 7, 8

Patients with aPTT <50 seconds have a 15-fold increased risk of recurrent venous thromboembolism, according to the American College of Cardiology 5
Subtherapeutic aPTT values (50-59 seconds) still carry increased thrombotic risk, as reported by the American College of Cardiology 5
aPTT >90 seconds increases bleeding risk without additional antithrombotic benefit, according to the American College of Cardiology 5

For heparin resistance, consider switching to anti-factor Xa monitoring with target range 0.35-0.7 units/mL, as recommended by the American College of Chest Physicians 7, 8
For acute coronary syndromes, lower doses of heparin are recommended, such as 60-70 units/kg bolus (max 5,000 units), then 12-15 units/kg/h (max 1,000 units/h) for unstable angina/NSTEMI, according to the American College of Chest Physicians 8
Dosing regimens must be modified when heparin is combined with thrombolytic therapy or platelet GP IIb/IIIa antagonists, as recommended by the American College of Cardiology 5